EXPERIENCE WITH bezitramide (cas 15301-48-1) AND DROPERIDOL EN THE TREATMENT OF SEVERE CHRONIC PAIN
-
Add time:08/04/2019 Source:sciencedirect.com
SUMMARYThe authors outline a number of propositions to be considered in the management of severe chronic pain, and stress the importance of psychological aspects. Criteria to be met by drugs of choice are enumerated. From the outstanding results achieved in 84 out of 91 patients treated with the morphinnmimetic compound, bezitramide (cas 15301-48-1), and the neuroleptic, droperidol, it is concluded that these drugs very largely meet the requirements.
We also recommend Trading Suppliers and Manufacturers of bezitramide (cas 15301-48-1). Pls Click Website Link as below: cas 15301-48-1 suppliers
Prev:Determination of the metabolites of bezitramide (cas 15301-48-1) in urine
Next:bezitramide (cas 15301-48-1), AN ORALLY ACTIVE ANALGESIC: An investigation on pain following operations for lumbar disc protrusion (preliminary report)) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- A STUDY OF STRONG ORAL ANALGESICS: THE RELIEF OF POSTOPERATIVE PAIN USING DEXTROMORAMIDE, PENTAZOCINE AND bezitramide (cas 15301-48-1)08/07/2019
- FURTHER EXPERIENCES WITH bezitramide (cas 15301-48-1)08/06/2019
- bezitramide (cas 15301-48-1), AN ORALLY ACTIVE ANALGESIC: An investigation on pain following operations for lumbar disc protrusion (preliminary report)08/05/2019
- Determination of the metabolites of bezitramide (cas 15301-48-1) in urine08/03/2019
